Skip to Main Content

Paper Details

Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
JAMA Ophthalmol
108
2017
Author NameAffiliation
Adam R GlassmanJaeb Center for Health Research
Lee M JampolFeinberg School of Medicine, Northwestern University
Michele MeliaJaeb Center for Health Research
  • 1 - 3

Datasets

Release 1.2